Research Topics
| Todd M BrownSummaryAffiliation: University of Alabama at Birmingham Country: USA Publications
| Collaborators
|
Detail Information
Publications
Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria?Todd M Brown
Health Services Research Training Program, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
J Womens Health (Larchmt) 17:841-7. 2008..Whether the IDF definition identifies a greater prevalence of the metabolic syndrome than the ATP III definition in women with coronary artery disease (CAD) is unknown...
Drugs are not enough: the metabolic syndrome--a call for intensive therapeutic lifestyle changeTodd M Brown
Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
J Cardiometab Syndr 4:20-5. 2009..More emphasis on therapeutic lifestyle change in addition to intensive pharmacologic therapy is needed to reduce MetS prevalence in patients with coronary artery disease...
Predictors of cardiac rehabilitation referral in coronary artery disease patients: findings from the American Heart Association's Get With The Guidelines ProgramTodd M Brown
University of Alabama at Birmingham, Birmingham, AL 35294, USA
J Am Coll Cardiol 54:515-21. 2009..Our purpose was to determine factors independently associated with cardiac rehabilitation referral, which are currently not well described at a national level...
Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic and Racial Differences in Stroke (REGARDS) studyTodd M Brown
Division of Cardiovascular Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Am Heart J 159:385-91. 2010..The International Diabetes Federation (IDF) and Adult Treatment Panel (ATP) III define metabolic syndrome (MetSyn) differently, with unclear implications for cardiovascular disease (CVD) risk...
Health Professional Shortage Areas, insurance status, and cardiovascular disease prevention in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) StudyTodd M Brown
University of Alabama at Birmingham, Division of Cardiovascular Diseases, USA
J Health Care Poor Underserved 22:1179-89. 2011..Less medication use for CVD prevention was not associated with HPSA status, but less statin use was associated with lack of insurance...
Association of race and sex with risk of incident acute coronary heart disease eventsMonika M Safford
School of Medicine, University of Alabama, Birmingham, AL 35294, USA
JAMA 308:1768-74. 2012..It is unknown whether long-standing disparities in incidence of coronary heart disease (CHD) among US blacks and whites persist...
Awareness and management of chronic disease, insurance status, and health professional shortage areas in the REasons for Geographic And Racial Differences in Stroke (REGARDS): a cross-sectional studyRaegan W Durant
University of Alabama at Birmingham School of Medicine, 1717 11th Avenue South, Birmingham, AL 35294, USA
BMC Health Serv Res 12:208. 2012..We examined variation in awareness, treatment, and control of hypertension, diabetes, and hyperlipidemia according to both geographic and financial access to care...
Epidemiology of obesity, the metabolic syndrome, and chronic kidney diseaseRikki M Tanner
Department of Epidemiology, University of Alabama at Birmingham, 1665 University Boulevard, Suite 230J, Birmingham, AL 35294, USA
Curr Hypertens Rep 14:152-9. 2012..Evidence suggests that lifestyle modifications such as weight reduction, reduced dietary fat intake and cholesterol, and pharmacologic treatments may reduce the burden of MetS and thus the risk for CKD, albuminuria, and ESRD...
Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study)Rikki M Tanner
Department of Epidemiology, University of Alabama at Birmingham, USA
Am J Cardiol 108:227-32. 2011..15, 95% confidence interval 0.92 to 1.39). In conclusion, MS is associated with an increased prevalence of AF. Further studies investigating a potential mechanism for this excess risk are warranted...
Cardiac rehabilitation outcomes: impact of comorbidities and ageJennifer Listerman
University of Alabama at Birmingham, Birmingham, Alabama, USA
J Cardiopulm Rehabil Prev 31:342-8. 2011..Medical comorbidities (CM) contribute to cardiac rehabilitation (CR) underutilization. Whether individuals with coronary heart disease and an increased CM burden achieve similar benefits from CR as those with a low CM burden is unknown...
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational studyMonika M Safford
Division of Preventive Medicine, University of Alabama at Birmingham School of Medicine, Medical Towers 621, 1717 11th Avenue South, Birmingham, AL 35294 4410, USA
BMC Health Serv Res 13:162. 2013..To confirm past reports of the clinical importance of microsize MIs, we also contrasted in-hospital, 28-day and 1-year mortality among those with microsize and nonmicrosize MI...
Cardioprotective medication use and risk factor control among US adults with unrecognized myocardial infarction: the REasons for Geographic And Racial Differences in Stroke (REGARDS) studyEmily B Levitan
Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL 35294 0022, USA
Vasc Health Risk Manag 9:47-55. 2013..The prevalence of cardioprotective medication use and blood pressure and low-density lipoprotein cholesterol control among individuals with UMI is unknown...
Exercise as a treatment for the risk of cardiovascular diseaseBilal Aijaz
Division of Cardiovascular Diseases, Department of Medicine, University of Alabama at Birmingham, LHRB 306 701, 19th Street South, Birmingham, AL, 35294, USA
Curr Treat Options Cardiovasc Med 12:329-41. 2010..Health care providers have an opportunity and a responsibility to include exercise counseling in routine office visits...
Assessing patient recall of discharge instructions for acute myocardial infarctionBonnie K Sanderson
University Hospital, University of Alabama at Birmingham, Birmingham, Alabama, USA
J Healthc Qual 31:25-33; quiz 34. 2009..Quality improvement strategies are needed to guide more effective provider-patient communication...
Management of stable patients with coronary heart disease: Clinical implications of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trialTodd M Brown
Division of Cardiovascular Diseases, University of Alabama at Birmingham, LHRB 306, 701 19th Street South, Birmingham, AL 35294, USA Health Services and Outcomes Research Training Program, University of Alabama at Birmingham, LHRB 306, 701 19th Street South, Birmingham, AL 35294, USA
J Clin Lipidol 1:564-74. 2007..We review the strengths, limitations, and clinical relevance of the COURAGE trial in the context of the current literature on the benefits of medical management and coronary revascularization in patients with stable CHD...
Biomarkers of atherosclerosis: clinical applicationsTodd M Brown
Preventive Cardiology, University of Alabama at Birmingham, Division of Cardiovascular Disease, 701 19th Street South LHRB 310, Birmingham, AL 35294 0007, USA
Curr Cardiol Rep 10:497-504. 2008..We review the recently published literature on blood-based biomarkers and examine whether incorporating these markers may improve clinical decision making...
